Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001825192-26-000002

Options or other derivatives

  • Chief Development Officer acquired 303,310 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jalota Deepika · Chief Development Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-05 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +303,310 303,310 D
Loading xslF345X05/form4-03092026_080350.xml…